Israel Porcine Vaccine Market (2025-2031) | Companies, Industry, Trends, Segmentation, Value, Forecast, Competitive Landscape, Share, Analysis, Size & Revenue, Outlook, Growth

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Israel Country Macro Economic Indicators

3.2 Israel Porcine Vaccine Market Revenues & Volume, 2021 & 2031F

3.3 Israel Porcine Vaccine Market - Industry Life Cycle

3.4 Israel Porcine Vaccine Market - Porter's Five Forces

3.5 Israel Porcine Vaccine Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F

3.6 Israel Porcine Vaccine Market Revenues & Volume Share, By End User, 2021 & 2031F

3.7 Israel Porcine Vaccine Market Revenues & Volume Share, By Technology, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing demand for pork products and rising consumption of pork in Israel.

4.2.2 Growing awareness about animal health and the need for vaccination to prevent diseases.

4.2.3 Government initiatives to promote animal health and welfare in the country.

4.3 Market Restraints

4.3.1 Stringent regulations and approval processes for vaccine registration in Israel.

4.3.2 Limited availability of advanced technologies and expertise in the field of porcine vaccine development.

6.1 Israel Porcine Vaccine Market, By Disease Indication

6.1.1 Overview and Analysis

6.1.2 Israel Porcine Vaccine Market Revenues & Volume, By Disease Indication, 2021- 2031F

6.1.3 Israel Porcine Vaccine Market Revenues & Volume, By Diarrhea, 2021- 2031F

6.1.4 Israel Porcine Vaccine Market Revenues & Volume, By Swine Influenza, 2021- 2031F

6.1.5 Israel Porcine Vaccine Market Revenues & Volume, By Arthritis, 2021- 2031F

6.1.6 Israel Porcine Vaccine Market Revenues & Volume, By Bordatella Rhinitis, 2021- 2031F

6.1.7 Israel Porcine Vaccine Market Revenues & Volume, By Porcine Reproductive and Respiratory Virus (PRRSV), 2021- 2031F

6.1.8 Israel Porcine Vaccine Market Revenues & Volume, By Porcine Circovirus Associated Disease (PCVAD), 2021- 2031F

6.2 Israel Porcine Vaccine Market, By End User

6.2.1 Overview and Analysis

6.2.2 Israel Porcine Vaccine Market Revenues & Volume, By Veterinary Hospitals, 2021- 2031F

6.2.3 Israel Porcine Vaccine Market Revenues & Volume, By Hog/Pig Production Farms, 2021- 2031F

6.3 Israel Porcine Vaccine Market, By Technology

6.3.1 Overview and Analysis

6.3.2 Israel Porcine Vaccine Market Revenues & Volume, By Inactivated Vaccines, 2021- 2031F

6.3.3 Israel Porcine Vaccine Market Revenues & Volume, By Live Attenuated Vaccines, 2021- 2031F

6.3.4 Israel Porcine Vaccine Market Revenues & Volume, By Toxoid Vaccines, 2021- 2031F

6.3.5 Israel Porcine Vaccine Market Revenues & Volume, By Recombinant Vaccines, 2021- 2031F

6.3.6 Israel Porcine Vaccine Market Revenues & Volume, By Conjugate Vaccines, 2021- 2031F

6.3.7 Israel Porcine Vaccine Market Revenues & Volume, By DNA Vaccines, 2021- 2031F

7.1 Israel Porcine Vaccine Market Export to Major Countries

7.2 Israel Porcine Vaccine Market Imports from Major Countries

8.1 Percentage increase in the adoption of vaccination programs among pig farmers.

8.2 Number of new product launches and innovations in the porcine vaccine market in Israel.

8.3 Growth in research and development investments by key players in the market.

9.1 Israel Porcine Vaccine Market Opportunity Assessment, By Disease Indication, 2021 & 2031F

9.2 Israel Porcine Vaccine Market Opportunity Assessment, By End User, 2021 & 2031F

9.3 Israel Porcine Vaccine Market Opportunity Assessment, By Technology, 2021 & 2031F

10.1 Israel Porcine Vaccine Market Revenue Share, By Companies, 2024

10.2 Israel Porcine Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters